5 research outputs found
Moriarty et al database ear mite treatment study
Data collected from field examinations of island foxes in this study, as well as lab analysis results (histopathology, immunology, mite counts, etc
Otitis and ceruminous gland hyperplasia (CGH) scores in a subset of Island foxes recaptured at t<sub>3</sub>.
<p>Comparison between treated and untreated foxes at t<sub>3</sub>, and between t<sub>0</sub> and t<sub>3</sub> within each group. Number of treated and untreated foxes at t<sub>0</sub> and t<sub>3</sub> (37, 33). Range of values for otitis and CGH shown in parentheses above each bar. Foxes excluded from analyses: three treated and two untreated foxes at t<sub>0</sub>, one treated and untreated fox at t<sub>3</sub> (non-diagnostic biopsy), 18 treated and 22 untreated foxes at t<sub>3</sub> (not recaptured). <sup>a,b</sup> Significant difference (Mann-Whitney U test, p < 0.001). <sup>c, d, e</sup> Significant difference (Friedman test, p ≤ 0.007).</p
Scoring criteria: otoscopic assessment of mites and histopathologic assessment of otitis and ceruminous gland hyperplasia (CGH).
<p>Scoring criteria: otoscopic assessment of mites and histopathologic assessment of otitis and ceruminous gland hyperplasia (CGH).</p
IgG levels in Santa Catalina Island treated/untreated and uninfected/infected foxes, and Santa Cruz Island foxes.
<p>IgG level: a relative quantity of mite-specific antibody (determined by interpolation from a four-point calibration curve, see text for further explanation). Number of treated and untreated foxes (t<sub>0</sub>: 59, 57; t<sub>1</sub>: 38, 42; t<sub>2</sub>: 24, 36 t<sub>3</sub>: 40, 36); number of uninfected and infected foxes (t<sub>0</sub>: 116; t<sub>1</sub>: 31, 49; t<sub>2</sub>: 25, 35 t<sub>3</sub>: 42, 35); number of SCZ foxes (43). Range of values for IgG shown in parentheses above each bar. Foxes excluded from analyses: one untreated/infected fox at t<sub>0</sub> and one treated/uninfected fox at t<sub>1</sub> (missing IgG level). <sup>a, b</sup> Significant difference (Friedman test, p < 0.001). <sup>c</sup> Significant difference between SCZ foxes vs. SCA treated and untreated foxes at all capture events (Mann-Whitney U test, p ≤ 0.01), except for SCA treated foxes at t<sub>3</sub> (p = 0.6). <sup>d, e, f</sup> Significant difference (Mann-Whitney U test, p ≤ 0.01). <sup>g, h</sup> Significant difference (Friedman test, p ≤ 0.004). <sup>i</sup> Significant difference between SCZ foxes vs. SCA infected and uninfected foxes at all capture events (Mann-Whitney U test, p ≤ 0.001), except for SCA uninfected foxes at t<sub>2</sub> (p = 0.1) and t<sub>3</sub> (p = 0.9).</p
Ear mite prevalence and intensity of infection in treated and untreated Island foxes.
<p>Prevalence: number of foxes with mites/total number of foxes. Intensity of infection: median ear mite count. Number of treated and untreated foxes (t<sub>0</sub>: 59, 58; t<sub>1</sub>: 39, 42; t<sub>2</sub>: 24, 36; t<sub>3</sub>: 40, 36). Range of values for mite intensity shown in parentheses above each bar. Foxes excluded from analysis: one untreated fox at t<sub>1</sub> and t<sub>2</sub> (missing mite count), one untreated fox at t<sub>3</sub> (accidentally treated at t<sub>2</sub>). <sup>a, b, c</sup> Significant difference (Pearson’s chi-square test, p < 0.001). <sup>d</sup> Significant difference (McNemar’s chi-square test, p< 0.001). <sup>e, f, g</sup> Significant difference (Mann-Whitney U test, p < 0.001). <sup>h, i</sup> Significant difference (Friedman test, p < 0.001, p = 0.02).</p